Latest Hypolipidemic agent Stories
Less than one percent of children aged 12 to 17 are likely to need drug treatments for high cholesterol, according to a new study.
American Heart Association rapid access journal report: Study highlights: -- Cholesterol-lowering drug adherence drops with an increase in VA prescription co-payments. -- The odds of going for 90 straight days without medication was three times higher among patients in the all co-payment group and twice as high in patients in the some co-payment group when compared to the exempt group (received prescriptions without a co-payment). -- Researchers suggest charging lower co-payments for...
The US Food and Drug Administration on Thursday backed the cholesterol-lowering drug Vytorin following a review lasting almost one year.
Pregnant women or those hoping to start or extend a family should avoid using the cholesterol-lowering drugs statins, say scientists.
WASHINGTON, Nov. 14 /PRNewswire-USNewswire/ -- For the first time ever, a new study is providing direct evidence that cholesterol-lowering drugs called statins can prevent heart attacks, strokes and deaths among women.
A Michigan State University researcher says she is studying whether a popular class of cholesterol-lowering drugs -- statins -- may cause muscle problems.
WASHINGTON, Nov. 10 /PRNewswire-USNewswire/ -- WomenHeart today urged women to talk with their doctors about heart disease risk factors in light of new research demonstrating the impact of statin therapy (cholesterol-lowering drugs) on cardiovascular events in women.
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) holds U.S. and global patent rights for the use of statin drugs for the prevention and treatment of Alzheimer's disease (AD). The newly published results of a major long-term study (J Neurol NeuroSurg Psychiatry Oct.
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) holds U.S. and global patent rights for the use of statin drugs for the prevention and treatment of Alzheimer's disease (AD), including for patients at risk for AD because of vascular-related risk factors or disease.
The U.S. Food and Drug Administration says it has determined statins do not increase the incidence of amyotrophic lateral sclerosis, or Lou Gehrig's Disease.